EGFR and laryngotracheoesophageal cleft: Furthermore, considering the proximity of the rs2293347 SNP to the tyrosine kinase structural domain (Mitsudomi and Yatabe, 2010) and its correlation with the efficacy response of TKIs, this SNP may be a good candidate for future clinical trials targeting the EGFR gene to improve the clinical outcomes of LC patients.